EVGN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Evogene Ltd (EVGN) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's financial performance is significantly declining, technical indicators are bearish, and there are no positive catalysts or trading signals to suggest a potential upside. The lack of recent news or analyst ratings further diminishes confidence in the stock.
The technical indicators for EVGN are bearish. The MACD histogram is negative and contracting, RSI is neutral at 36.926, and moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level at 0.824, with resistance levels at 0.973 and 1.019. The price has declined by 1.83% in the regular market and 3.50% in pre-market trading.
NULL identified. There are no recent news articles, trading trends, or significant insider or hedge fund activity to suggest positive momentum.
The company's financial performance has deteriorated significantly in Q3 2025, with revenue down 82.07% YoY, net income down 150.77% YoY, and EPS down 133.59% YoY. Additionally, the market sentiment is neutral, and there are no recent trading signals or influential figure activity to support a bullish outlook.
In Q3 2025, Evogene Ltd reported a sharp decline in financial metrics: Revenue dropped to $312,000 (-82.07% YoY), Net Income dropped to $3,874,000 (-150.77% YoY), and EPS dropped to 0.44 (-133.59% YoY). The only positive indicator was an increase in Gross Margin to 49.68% (+23.86% YoY).
No recent analyst ratings or price target changes are available for EVGN.
